Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antipsychotics/oksendamine

Link salvestatakse lõikelauale
Leht 1 alates 333 tulemused

Use of antipsychotic medication in chemotherapy-induced nausea and vomiting.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Nausea and vomiting continue to present significant problems for cancer patients undergoing chemotherapy. Initial work suggested an important role for central dopamine transmission in the underlying pathophysiology. However, recent evidence has implicated central and peripheral serotonin release.
Small rodents (mice, rats) are the species of choice for evaluating the pharmacology of centrally acting compounds, such as antipsychotics, whereas toxicology data are routinely obtained from other species (rabbits, dogs, monkeys). Whilst there is a substantial number of "therapeutically relevant"
Background To determine the feasibility and efficacy of olanzapine, which is approved by the Pharmaceuticals and Medical Devices Agency as multi acting receptor targeted antipsychotic agent of the thienobenzodiazepine class, for prevention of chemotherapy-induced nausea and vomiting (CINV) in

[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Many recommendations concerning the treatment of nausea and vomiting in palliative care patients exist but what is the evidence for this? Most studies dealing with this topic have focused on cancer patients under chemotherapy and/or radiation therapy or on patients with postoperative
Atypical antipsychotics are efficacious for chemoprophylaxis against chemotherapy-induced nausea and vomiting, but perioperative investigations have been scant. We sought to examine the association between chronic atypical antipsychotic therapy and the likelihood of postoperative

Persistent supersensitivity vomiting following neuroleptic withdrawal in an adolescent.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Vomiting during neuroleptic withdrawal in children.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Increased vomiting among patients treated with neuroleptics.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Neuroleptic-induced emesis: a new indication for clozapine?

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

[Comprehensive treatment of vomiting in pregnant women using neuroleptics and parenteral feeding].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

A case report of vomiting related to the interactions of antipsychotics and benztropine.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

[On the use of a neuroleptic in experimental phase in the nausea and vomiting of the pregnant woman].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE Newer drugs incorporated in prophylactic regimens for chemotherapy-induced nausea and vomiting (CINV) have resulted in significantly reduced rates of this feared complication of cytotoxic chemotherapy. However, both delayed chemotherapy-induced nausea and breakthrough CINV remain difficult

Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Twenty-one schizophrenic subjects, who had been neuroleptic-free, were tested for responsiveness to dopaminergic agonists: Apomorphine emesis threshold was determined and change in psychopathology after 0.5 mg/kg d-amphetamine orally was rated. The subjects' subsequent response to neuroleptic
The Glutamatergic system is the most important excitatory system of the human brain. Dysfunction of this system plays an important role in the pathogenesis of numerous psychiatric disorders, including schizophrenia. According to the glutamatergic hypothesis of schizophrenia augmentation of the
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge